American Journal of Clinical Nutrition, Vol 63, 242-248, Copyright © 1996 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection

F Muller, AM Svardal, P Aukrust, RK Berge, PM Ueland and SS Froland
Medical Department A, University of Oslo, National Hospital, Norway.

Oxidative stress has been suggested to be an important factor in the immunopathogenesis of human immunodeficiency virus (HIV) infection. Reduced plasma thiols may lead to production of reactive oxygen species, thus contributing to the oxidative stress. We quantified the total, reduced, and protein-bound forms of the thiols homocysteine, cysteine, cysteinylglycine, and methionine in plasma from 21 HIV- infected patients and 15 healthy control subjects and compared the results with clinical and immunologic indexes. The HIV-infected patients had significantly higher concentrations of reduced homocysteine in plasma compared with control subjects. No significant differences in reduced homocysteine concentrations were noted when asymptomatic and symptomatic HIV-infected patients were compared, and we did not find any relation between reduced homocysteine concentrations and other markers of immunodeficiency. The HIV-infected patients had normal total homocysteine concentrations. The reduced cysteinylglycine concentration tended to be elevated in the patient group. No differences between HIV-infected patients and control subjects were found for reduced or total cysteine. Compared with control subjects, the HIV-infected patients had lower concentrations of methionine in plasma, and a significant correlation was found between low concentrations of methionine and low CD4+ lymphocyte counts in blood. Elevated concentrations of reduced homocysteine could possibly contribute to formation of reactive oxygen species, leading to accelerated immunologic deterioration and increased HIV replication.

This article has been cited by other articles:

				A. F Remacha and J. Cadafalch Reply to D Fuchs et al Am. J. Clinical Nutrition, November 1, 2003; 78(5): 1046 - 1047. [Full Text] [PDF]

				A. F Remacha, J. Cadafalch, P. Sarda, M. Barcelo, and M. Fuster Vitamin B-12 metabolism in HIV-infected patients in the age of highly active antiretroviral therapy: role of homocysteine in assessing vitamin B-12 status Am. J. Clinical Nutrition, February 1, 2003; 77(2): 420 - 424. [Abstract] [Full Text] [PDF]

				C. Bergmark, M. A. Mansoor, A. Svardal, and U. d. Faire Redox Status of Plasma Homocysteine and Related Aminothiols in Smoking and Nonsmoking Young Adults, Clin. Chem., October 1, 1997; 43(10): 1997 - 1999. [Full Text]

				M. A. Vilaseca, D. Moyano, I. Ferrer, and R. Artuch Total Homocysteine in Pediatric Patients Clin. Chem., April 1, 1997; 43(4): 690 - 692. [Full Text]